Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | 0.85% | 93.83 | 1.9% | $1197.07m | |
| BMY | Bristol-Myers Squibb Co. | 0.71% | 61.32 | 1.0% | $1025.25m | |
| JNJ | Johnson & Johnson | 0.37% | 147.27 | 0.7% | $985.01m | |
| PFE | Pfizer Inc. | -0.22% | 35.93 | 0.9% | $950.41m | |
| MRK | Merck & Co., Inc. | 0.82% | 82.22 | 0.7% | $866.82m | |
| LLY | Eli Lilly & Co. | -1.02% | 149.17 | 1.1% | $513.08m | |
| AZN | AstraZeneca Plc | -0.04% | 53.85 | 1.2% | $284.98m | |
| NVS | Novartis AG | 0.93% | 85.91 | 0.2% | $149.95m | |
| GSK | GlaxoSmithKline Plc | 0.11% | 41.70 | 0.2% | $128.57m | |
| NVO | Novo Nordisk A/S | 0.23% | 64.49 | 0.1% | $86.32m | |
| SNY | Sanofi | 0.30% | 50.10 | 0.2% | $78.21m | |
| RGEN | Repligen Corp. | -1.28% | 120.26 | 7.1% | $68.18m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 1.08% | 68.14 | 0.0% | $53.16m | |
| TPTX | Turning Point Therapeutics, Inc. | 1.28% | 62.98 | 0.0% | $37.37m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.49% | 126.30 | 3.4% | $35.33m |
Company Profile
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.